Akebia Therapeutics (AKBA) Return on Capital Employed Growth (1y) (2015 - 2026)
Akebia Therapeutics (AKBA) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 89.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,195.00 |
| 10 | Akebia Therapeutics | 325.80 Mn | 163.20 Mn | 41.25 Mn | 1,535.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,535.00 |
| Dec 31, 2025 | 4,928.00 |
| Sep 30, 2025 | 3,153.00 |
| Jun 30, 2025 | 3,095.00 |
| Mar 31, 2025 | 866.00 |
| Dec 31, 2024 | -455.00 |
| Sep 30, 2024 | 837.00 |
| Jun 30, 2024 | 2,074.00 |
| Mar 31, 2024 | -103.00 |
| Dec 31, 2023 | -355.00 |
| Sep 30, 2023 | 1,617.00 |
| Jun 30, 2023 | -248.00 |
| Mar 31, 2023 | 7,326.00 |
| Dec 31, 2022 | 5,694.00 |
| Sep 30, 2022 | 2,005.00 |
| Jun 30, 2022 | 1,446.00 |
| Mar 31, 2022 | -1,110.00 |
| Dec 31, 2021 | -720.00 |
| Sep 30, 2021 | 483.00 |
| Jun 30, 2021 | 395.00 |